Clinical Trials Logo

Clinical Trial Summary

The contribution of diesel exhaust (DE) to health, especially children's health, is of tremendous public health interest. DE has been associated with worsening asthma and allergies, among other important health effects. Reducing DE exposures has become a major regulatory initiative, and federal, state, and local jurisdictions are investing hundreds of millions of dollars in retrofitting diesel engines in school buses and other changes to reach this goal.

The U.S. Environmental Protection Agency's recent regulations require all on-road diesel vehicles to change to low emission engines and ultra-low-sulfur fuels by 2007 (US EPA '00). In spring 2003, the U.S. EPA announced a nationwide voluntary school bus retrofit initiative. In July 2003, the Washington Legislature enacted a statewide "Diesel Solutions" program that provides 25 million dollars by 2008 to retrofit school diesel buses with cleaner burning engines and fuels, making it one of the largest and most active voluntary school bus retrofit program in the country. If risk assessment estimates are accurate, these changes will have a large public health impact, especially on children who ride school buses daily. However, no studies to-date have rigorously examined school children's exposure to diesel exhaust (DE) and its health effects, nor such a significant change in vehicular pollution control. We propose to seize this opportunity of a large natural experiment taking place in the Puget Sound area and conduct a study to assess health effects from diesel bus exhaust before and after the retrofit of diesel bus fleets between 2005 and 2007. The specific aims of the study are to:

1. Determine whether asthmatic children changing to retrofitted buses with cleaner fuels and engines have a reduction in sub-clinical and clinical asthma severity.

2. Determine if increased levels of DE exposure lead to an increase in acute clinical and sub-clinical features of asthma in children.

3. Quantify the levels and changes in particle and toxic gas exposures to DE in 3 groups of children commuting to school by retrofitted buses or private cars, old diesel buses to be retrofitted later, and old diesel buses through the study.

Sub-aim 3: Use the time-activity information, personal exposure measurements, and on-bus monitoring data to construct an exposure model to predict individual exposures to DE for all subjects.


Clinical Trial Description

We will recruit 450 subjects ranging from 9 to 11 years old (or 3rd to 5th graders). These children who commute to school will perform repeated monthly measures of pulmonary function tests using spirometry, pulmonary inflammation via exhaled breath, and asthma symptoms and clinical encounters, up to 3 school years. These 500 children will represent 3 exposure scenarios: 1) one group of 125 children riding retrofitted school buses or private cars; 2) 250 children riding old buses who will change to retrofitted buses during the first or second year of the study; and 3) 125 children who ride old diesel buses through the study. All subjects will be either healthy or having physician-diagnosed asthma with severity ranging from mild intermittent to moderate persistent. Personal exposure monitoring of particulate matter, CO, NO2, and SO2 will be performed on a subset of 144 asthmatic subjects, with each subject being monitored for up to 2 days, in each monitoring year.

Subjects participating in the study will wear a small backpack containing several personal air monitors measuring real-time particulate matter concentrations and carbon monoxide concentrations as well as integrated (24 hour averaged) measurements of SO2 and NO2. The children's personal monitoring will begin when they wake up in the morning and continue for 24-hours. When wearing the backpack is inconvenient, such as when sleeping, the monitoring equipment should be placed in close proximity to the subject. Once the subject arrives at school, s/he will be asked to perform three respiratory tests: exhaled nitric oxide, exhaled breath condensate, and spirometry. At the end of the school day, the subject will be asked to perform the same two tests of lung function as earlier, plus an additional test of exhaled breath condensate. The subject will then continue his/her day as normal. A technician will replace the filter in the particulate matter monitor between 6 and 7 PM. We will repeat the same monitoring procedure the following morning when the subject wakes up for another 24-h. Monitoring will stop on the third morning when the subjects wake up. In addition to the personal monitoring, a monitoring kit will be installed in the subject's school bus and will be operated by a technician. This in-vehicle monitoring kit includes everything contained in the personal monitoring kit, plus a P-TRAK (TSI, model 8525) for real-time ultra-fine particle counts, two Harvard Personal Environmental Monitors (HPEM) with Teflon and quartz filters respectively for determining elemental carbon fractions, an EcoChem PAS2000CE monitor for polycyclic aromatic hydrocarbons (PAHs), and a global positioning system personal acquisition logger (GPS-PAL). The following timeline shows the typical daily schedule for a subject participating in the study. ;


Study Design

Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT00527345
Study type Observational
Source National Institute of Environmental Health Sciences (NIEHS)
Contact
Status Completed
Phase N/A
Start date March 2005
Completion date July 2009

See also
  Status Clinical Trial Phase
Terminated NCT04410523 - Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma Phase 2
Completed NCT04624425 - Additional Effects of Segmental Breathing In Asthma N/A
Active, not recruiting NCT03927820 - A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR) N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT03694158 - Investigating Dupilumab's Effect in Asthma by Genotype Phase 4
Terminated NCT04946318 - Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma Phase 2
Completed NCT04450108 - Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients N/A
Completed NCT03086460 - A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH) Phase 2
Completed NCT01160224 - Oral GW766944 (Oral CCR3 Antagonist) Phase 2
Completed NCT03186209 - Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE) Phase 3
Completed NCT02502734 - Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma Phase 3
Completed NCT01715844 - L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics Phase 1
Terminated NCT04993443 - First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036 Phase 1
Completed NCT02787863 - Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology Phase 4
Recruiting NCT06033833 - Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study Phase 2
Completed NCT03257995 - Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma. Phase 2
Completed NCT02212483 - Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients N/A
Recruiting NCT04872309 - MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
Withdrawn NCT01468805 - Childhood Asthma Reduction Study N/A
Recruiting NCT05145894 - Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device